Home » Topics » BioWorld Science

BioWorld Science
RSS

Tau-targeting therapy reduces epilepsy and autism behaviors in model of Dravet syndrome

June 3, 2022

RIKEN presents new immunostimulants

June 3, 2022

New lysophosphatidic acid receptor 1 antagonists patented by Humanwell Healthcare

June 3, 2022

Guangzhou Henovcom Bioscience discovers autotaxin inhibitors

June 3, 2022

Hongyun Biotech presents new MAP4K1 inhibitors

June 3, 2022

New Rho kinase 2 inhibitors identified at Medshine Discovery

June 3, 2022

RGS16 impacts CD8+ T-cell exhaustion and limits therapy efficacy

June 3, 2022

New animal models reveal potential topical therapies for congenital nevi

June 3, 2022

Kavli Neuroscience Prize honors four for genetic discoveries

June 2, 2022

New STING modulators display potent immune activation and in vivo activity

June 2, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...